Biomarkers and Personalized Approach to Cancer Group (BioPAC)

2023Activity indicators

4 European projects: H2020 (NANO4GLIO, VISION, NExT, HE-PANCAID)
5 public competitive projects led: ISCIII, MICINN
4 competitive private projects
2 private projects led
119 clinical studies led
8 competitive HR contracts
18 publications
IF: 125.10
Q1 publications: 12 (67%)
D1 publications: 6 (33%)
3 thesis
1 award
Evaluators in public entities: 4 PI
Member of editorial committees: 2 PI
3 hosted visitors and 2.5 months stay:
- Department of Propaedeutic Surgery, Faculty of Medicine of Athens, Greece.
- Department of Pathology, Athens General Hospital 'Hippocratio' (Greece).
8 months of stay in foreign centers:
- University Hospital Zurich (Zurich, Switzerland)
- Paris Lodron University of Salzburg - PLUS (Salzburg, Austria)
- Department of Surgery, Aretaieio Hospital (Athens, Greece)
- Fraunhofer Institute for Biomedical Engineering (IBMT) (Sulzbach, Germany)

Incorporation of new researchers from the Medical Oncology Department of the Ramón y Cajal University Hospital, reinforcing the translational capacity of the group and opening up new lines of research.
Strengthening of the group in its international aspect. In 2023, the European project of the Horizon Europe programme, PANCAID-101096309 'PANcreatic CAncer Initial Detection via liquid biopsy' led by Dr Alfredo Carrato and Dr Julie Earl, was launched. As well as the VESPA study, a clinical trial whose PI is Dr Mercedes Rodríguez and which forms part of the European project of the Horizon Europe programme, REMEDi4ALL-101057442.
ISCCIII Biomodels and Biobanks Platform - Units of the ISCIII Platforms to support R&D&I in Biomedicine and Health Sciences (ISCIII: PT23/00098): Leading PDXs and Organoids platforms.
COST Consortium: Identification of Biological Markers for Prevention and Translational Medicine in Pancreatic Cancer (TRANSPAN:CA21116).
EvolutiONC GI Project Award granted to the Colorectal Cancer Patient School as best healthcare practice in the management of patients with digestive tumours. The school is promoted by the hospital's Multidisciplinary Colorectal Cancer Committee and coordinated by Dr. Reyes Ferreiro.

	Articles	Accum. FI	Mean FI	Articles Q1 or Q2	% in Q1 or Q2	Articles D1	% in D1
2019	6	51.59	8.60	6	100	3	50
2020	11	70.19	6.38	11	100	3	27
2021	9	96.74	10.75	9	100	2	22
2022	4	68.01	17.00	4	100	3	75
2023	18	125.10	6.95	17	94	6	33
	48	411.63	9.94	47	98	17	35